10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2020-11-16 (Q3 2020) | Holdings: 70 | Value: $5.5B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A S | Add 20% ($153.5M) | 16.68% | $912.0M | +8.04% | +2.34% | -5.71% | |
| FMTX - FORMA THERAPEUTICS HLDGS INC | 8.22% | $449.1M | +4.93% | -54.64% | |||
| CCXI - CHEMOCENTRYX INC | 4.84% | $264.5M | +4.55% | -32.97% | |||
| PCVX - VAXCYTE INC | Reduce 4% $(10.1M) | 4.77% | $260.9M | -4.00% | -27.26% | -31.01% | |
| TGTX - TG THERAPEUTICS INC | Reduce 31% $(106.0M) | 4.32% | $236.2M | +33.90% | +56.35% | -7.39% | |
| NKTX - NKARTA INC | New Purchase | 3.08% | $168.5M | -94.59% | +68.43% | -48.20% | |
| AXSM - AXSOME THERAPEUTICS INC | 2.65% | $145.0M | +50.44% | -2.09% | -53.03% | ||
| PHAT - PHATHOM PHARMACEUTICALS INC | 2.57% | $140.3M | -88.87% | +5.60% | -50.08% | ||
| MCRB - SERES THERAPEUTICS INC | New Purchase | 2.46% | $134.5M | -98.97% | -31.80% | -76.18% | |
| NVAX - NOVAVAX INC | Reduce 75% $(385.8M) | 2.38% | $129.9M | -92.23% | +204.59% | +104.55% | |
| ETNB - 89BIO INC | Add 50% ($40.4M) | 2.22% | $121.5M | -64.28% | -11.66% | -41.32% | |
| RYTM - RHYTHM PHARMACEUTICALS INC | Reduce 1% $(1.5M) | 2.04% | $111.4M | +203.58% | +31.79% | -44.95% | |
| MGNX - MACROGENICS INC | Reduce 5% $(5.3M) | 2.02% | $110.2M | -93.13% | -7.06% | -9.38% | |
| EIDX - EIDOS THERAPEUTICS INC | 2.00% | $109.3M | |||||
| ITOS - ITEOS THERAPEUTICS INC | New Purchase | 1.99% | $109.0M | -57.64% | +67.62% | +40.74% | |
| ZGNX - ZOGENIX INC | Add 49% ($32.5M) | 1.80% | $98.4M | +8.61% | -33.06% | ||
| ADVM - ADVERUM BIOTECHNOLOGIES INC | Add 21% ($16.6M) | 1.77% | $96.9M | -97.98% | +11.29% | -82.19% | |
| ADAP - ADAPTIMMUNE THERAPEUTICS PLC | Reduce 13% $(13.7M) | 1.65% | $90.4M | -94.32% | +31.61% | -15.90% | |
| TRIL - TRILLIUM THERAPEUTICS INC | 1.60% | $87.6M | -14.09% | ||||
| ARVN - ARVINAS INC | 1.59% | $86.7M | -72.60% | +215.76% | +222.88% | ||
| TVTX - RETROPHIN INC | 1.57% | $85.6M | -38.62% | +21.02% | +21.89% | ||
| KALA - KALA PHARMACEUTICALS INC | 1.49% | $81.6M | -98.86% | +24.08% | -72.37% | ||
| BDTX - BLACK DIAMOND THERAPEUTICS INC | 1.43% | $78.3M | -92.22% | -10.37% | -76.26% | ||
| LEGN - LEGEND BIOTECH CORP | Reduce 3% $(2.3M) | 1.36% | $74.3M | +15.27% | -5.35% | +104.06% | |
| IGMS - IGM BIOSCIENCES INC | 1.33% | $72.5M | -97.72% | +79.36% | +12.84% | ||
| KROS - KEROS THERAPEUTICS INC | 1.32% | $72.3M | -77.81% | -8.30% | -11.07% | ||
| VXRT - VAXART INC | New Purchase | 1.31% | $71.9M | -93.26% | +35.26% | +14.99% | |
| WVE - WAVE LIFE SCIENCES LTD | 1.21% | $66.0M | -20.49% | +25.68% | -50.77% | ||
| PMVP - PMV PHARMACEUTICALS INC | New Purchase | 1.11% | $60.7M | -97.05% | +12.62% | -24.75% | |
| DYN - DYNE THERAPEUTICS INC | New Purchase | 1.04% | $56.6M | -25.27% | -0.53% | -20.35% | |
| INZY - INOZYME PHARMA INC | New Purchase | 0.96% | $52.7M | -84.13% | -20.13% | -62.25% | |
| GERN - GERON CORP | 0.96% | $52.4M | -20.41% | +1.53% | -27.55% | ||
| AKUS - AKOUOS INC | 0.95% | $52.2M | -2.01% | -56.12% | |||
| ORTX - ORCHARD THERAPEUTICS PLC | Add 18% ($7.9M) | 0.93% | $50.6M | +65.91% | -67.64% | ||
| CRDF - CARDIFF ONCOLOGY INC | New Purchase | 0.85% | $46.7M | -78.71% | -24.88% | -69.24% | |
| RLAY - RELAY THERAPEUTICS INC | New Purchase | 0.78% | $42.6M | -93.44% | -10.43% | -27.20% | |
| INBX - INHIBRX INC | New Purchase | 0.70% | $38.3M | ||||
| ALEC - ALECTOR INC | Reduce 12% $(5.4M) | 0.70% | $38.1M | -88.84% | +65.08% | +75.93% | |
| CRNX - CRINETICS PHARMACEUTICALS INC | 0.67% | $36.5M | +139.05% | +16.57% | +102.74% | ||
| ARQT - ARCUTIS BIOTHERAPEUTICS INC | 0.62% | $34.1M | -36.87% | +63.74% | -9.49% | ||
| ARDX - ARDELYX INC | 0.60% | $32.9M | -37.35% | +23.75% | -82.44% | ||
| VRNA - VERONA PHARMA PLC | New Purchase | 0.58% | $31.8M | +1139.71% | +29.71% | -24.35% | |
| RLMD - RELMADA THERAPEUTICS INC | Reduce 8% $(2.7M) | 0.54% | $29.4M | -97.53% | +9.87% | -35.43% | |
| SCPH - SCPHARMACEUTICALS INC | 0.48% | $26.2M | -56.23% | -20.13% | -46.01% | ||
| IMGN - IMMUNOGEN INC | New Purchase | 0.46% | $25.3M | +57.07% | -5.06% | ||
| LRMR - LARIMAR THERAPEUTICS INC | 0.42% | $23.0M | -89.03% | -17.52% | -52.12% | ||
| STRO - SUTRO BIOPHARMA INC | Add 10% ($2.0M) | 0.39% | $21.3M | -95.24% | +37.40% | +6.88% | |
| OCUL - OCULAR THERAPEUTIX INC | 0.38% | $20.8M | -38.16% | +33.85% | -50.95% | ||
| PAND - PANDION THERAPEUTICS INC | New Purchase | 0.37% | $20.3M | +57.33% | |||
| PRVL - PREVAIL THERAPEUTICS INC | Reduce 23% $(5.9M) | 0.36% | $19.5M | ||||
| AVDL - AVADEL PHARMACEUTICALS PLC | Reduce 100% | 0.00% | $0.00 | ||||
| CLDX - CELLDEX THERAPEUTICS INC NEW | Reduce 100% | 0.00% | $0.00 | ||||
| CNCE - CONCERT PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| IMRA - IMARA INC | Reduce 100% | 0.00% | $0.00 | ||||
| LYRA - LYRA THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| MNTA - MOMENTA PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| PASG - PASSAGE BIO INC | Reduce 100% | 0.00% | $0.00 | ||||
| RPTX - REPARE THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| STSA - SATSUMA PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| SLDB - SOLID BIOSCIENCES INC | Reduce 100% | 0.00% | $0.00 | ||||
| STOK - STOKE THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| SNDX - SYNDAX PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| VSTM - VERASTEM INC | Reduce 100% | 0.00% | $0.00 | ||||